Latest Breaking News On - Paul tyahla - Page 1 : comparemela.com

BrainStorm to Present ALS Phase 3 Biomarker Analyses at Annual NEALS Meeting October 6th, 2021

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today.

United statesPaul tyahlaEric goldsteinChaim lebovitsStacy lindborgJames berryAmyotrophic lateral sclerosis consortiumCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsDrug administrationPrnewswire brainstorm cell therapeutics incNational ms societyEuropean medicines agencyHead of global clinical research at brainstormStorm cell therapeutics

BrainStorm to Present ALS Phase 3 Biomarker Analyses at Annual NEALS Meeting October 6th, 2021

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today.

United statesPaul tyahlaEric goldsteinChaim lebovitsStacy lindborgJames berryAmyotrophic lateral sclerosis consortiumCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsDrug administrationPrnewswire brainstorm cell therapeutics incNational ms societyEuropean medicines agencyHead of global clinical research at brainstormStorm cell therapeutics

BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today.

United statesJeffrey cohenPaul tyahlaEric goldsteinRalph kernChaim lebovitsCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsDrug administrationCleveland clinic mellen centerFree communicationsBrainstorm cell therapeutics ltdNational ms societyEuropean medicines agencyResearch in multiple sclerosis

BrainStorm Increases Commercial Manufacturing Capacity; Granted GMP Certification for a Second Production Site in Israel

BrainStorm Increases Commercial Manufacturing Capacity; Granted GMP Certification for a Second Production Site in Israel
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTel avivPaul tyahlaEric goldsteinChaim lebovitsCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsSourasky hospital institute for advanced cellular therapiesDrug administrationIsrael ministry of healthPrnewswire brainstorm cell therapeutics incTel aviv sourasky medical center hospitalEuropean medicines agencyEuropean union eu gmpsStorm cell therapeutics

BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update

BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
troyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from troyrecord.com Daily Mail and Mail on Sunday newspapers.

United statesJohn mullalyPaul tyahlaPreetam shahDavid setbounRalph kernChaim lebovitsStacy lindborgCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsGlobal head of clinical researchEuropean medicines agencyDrug administrationBrainstorm cell therapeuticsChief executive officer